Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Interchangeable Roles for E2F Transcriptional Repression by the Retinoblastoma Protein and p27KIP1-Cyclin-Dependent Kinase Regulation in Cell Cycle Control and Tumor Suppression.

Thwaites MJ, Cecchini MJ, Passos DT, Welch I, Dick FA.

Mol Cell Biol. 2017 Jan 4;37(2). pii: e00561-16. doi: 10.1128/MCB.00561-16. Print 2017 Jan 15.

PMID:
27821477
2.

p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer.

Zhao H, Lu Z, Bauzon F, Fu H, Cui J, Locker J, Zhu L.

Oncogene. 2017 Jan 5;36(1):60-70. doi: 10.1038/onc.2016.175. Epub 2016 May 16.

PMID:
27181203
3.

The non-canonical functions of p27(Kip1) in normal and tumor biology.

Sharma SS, Pledger WJ.

Cell Cycle. 2016 May 2;15(9):1189-201. doi: 10.1080/15384101.2016.1157238. Epub 2016 Apr 15.

4.

Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations.

Kadariya Y, Cheung M, Xu J, Pei J, Sementino E, Menges CW, Cai KQ, Rauscher FJ, Klein-Szanto AJ, Testa JR.

Cancer Res. 2016 May 1;76(9):2836-44. doi: 10.1158/0008-5472.CAN-15-3371. Epub 2016 Feb 19.

PMID:
26896281
5.

Genetically engineered mouse models of pituitary tumors.

Cano DA, Soto-Moreno A, Leal-Cerro A.

Front Oncol. 2014 Aug 1;4:203. doi: 10.3389/fonc.2014.00203. eCollection 2014. Review.

6.

Post-transcriptional gene expression control by NANOS is up-regulated and functionally important in pRb-deficient cells.

Miles WO, Korenjak M, Griffiths LM, Dyer MA, Provero P, Dyson NJ.

EMBO J. 2014 Oct 1;33(19):2201-15. doi: 10.15252/embj.201488057. Epub 2014 Aug 6.

7.

Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma.

Fish K, Chen J, Longnecker R.

Blood. 2014 Jan 23;123(4):530-40. doi: 10.1182/blood-2013-07-517649. Epub 2013 Oct 30.

8.

Doxycycline regulated induction of AKT in murine prostate drives proliferation independently of p27 cyclin dependent kinase inhibitor downregulation.

Wang H, Xu Y, Fang Z, Chen S, Balk SP, Yuan X.

PLoS One. 2012;7(7):e41330. doi: 10.1371/journal.pone.0041330. Epub 2012 Jul 23.

9.

Established and new mouse models reveal E2f1 and Cdk2 dependency of retinoblastoma, and expose effective strategies to block tumor initiation.

Sangwan M, McCurdy SR, Livne-Bar I, Ahmad M, Wrana JL, Chen D, Bremner R.

Oncogene. 2012 Nov 29;31(48):5019-28. doi: 10.1038/onc.2011.654. Epub 2012 Jan 30.

10.

p21, an important mediator of quiescence during pituitary tumor formation, is dispensable for normal pituitary development during embryogenesis.

Monahan P, Himes AD, Parfieniuk A, Raetzman LT.

Mech Dev. 2012 Jan-Feb;128(11-12):640-52. doi: 10.1016/j.mod.2011.11.002. Epub 2011 Dec 1.

11.

Mouse models of endocrine tumours.

Jones GN, Manchanda PK, Pringle DR, Zhang M, Kirschner LS.

Best Pract Res Clin Endocrinol Metab. 2010 Jun;24(3):451-60. doi: 10.1016/j.beem.2010.01.004. Review.

12.

Defective DNA double-strand break repair underlies enhanced tumorigenesis and chromosomal instability in p27-deficient mice with growth factor-induced oligodendrogliomas.

See WL, Miller JP, Squatrito M, Holland E, Resh MD, Koff A.

Oncogene. 2010 Mar 25;29(12):1720-31. doi: 10.1038/onc.2009.465. Epub 2010 Jan 11.

13.

The expression of AIP-related molecules in elucidation of cellular pathways in pituitary adenomas.

Heliövaara E, Raitila A, Launonen V, Paetau A, Arola J, Lehtonen H, Sane T, Weil RJ, Vierimaa O, Salmela P, Tuppurainen K, Mäkinen M, Aaltonen LA, Karhu A.

Am J Pathol. 2009 Dec;175(6):2501-7. doi: 10.2353/ajpath.2009.081131. Epub 2009 Oct 22.

14.

The notch target gene HES1 regulates cell cycle inhibitor expression in the developing pituitary.

Monahan P, Rybak S, Raetzman LT.

Endocrinology. 2009 Sep;150(9):4386-94. doi: 10.1210/en.2009-0206. Epub 2009 Jun 18.

15.

P21 and p27: roles in carcinogenesis and drug resistance.

Abukhdeir AM, Park BH.

Expert Rev Mol Med. 2008 Jul 1;10:e19. doi: 10.1017/S1462399408000744. Review.

16.

Transcriptional control of cell-cycle quiescence during C. elegans development.

Clayton JE, van den Heuvel SJ, Saito RM.

Dev Biol. 2008 Jan 15;313(2):603-13. Epub 2007 Nov 12.

17.

A mechanism misregulating p27 in tumors discovered in a functional genomic screen.

Garrett-Engele CM, Tasch MA, Hwang HC, Fero ML, Perlmutter RM, Clurman BE, Roberts JM.

PLoS Genet. 2007 Dec;3(12):e219.

18.

Differential gene expression of p27Kip1 and Rb knockout pituitary tumors associated with altered growth and angiogenesis.

Chien WM, Garrison K, Caufield E, Orthel J, Dill J, Fero ML.

Cell Cycle. 2007 Mar 15;6(6):750-7. Epub 2007 Mar 7.

19.

Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer.

Timmerbeul I, Garrett-Engele CM, Kossatz U, Chen X, Firpo E, Grünwald V, Kamino K, Wilkens L, Lehmann U, Buer J, Geffers R, Kubicka S, Manns MP, Porter PL, Roberts JM, Malek NP.

Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14009-14. Epub 2006 Sep 11.

20.

Retinoblastoma family genes.

Du W, Pogoriler J.

Oncogene. 2006 Aug 28;25(38):5190-200. Review.

Supplemental Content

Support Center